Edition:
United States

Profile: PuriCore PLC (PURI.L)

PURI.L on London Stock Exchange

20.25GBp
22 Jul 2016
Change (% chg)

0.00p (+0.00%)
Prev Close
20.25p
Open
20.25p
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,990
52-wk High
28.78p
52-wk Low
16.90p

PuriCore Plc is a biopharmaceutical company engaged in leveraging its immunomodulatory technology to protect and improve the health of adults and children. The Company is also engaged in development of small molecule therapies in inflammatory diseases with application in dermatology, ophthalmology and rare diseases, and also for applicability across various other diseases. The Company operates through two segments: Supermarket Retail and Health Sciences. It serves the Supermarket Retail sector and Wound Care market with various technologies and formulations based on its hypochlorous acid technology. In Supermarket Retail segment, the products are used by supermarket retailers across the United States and Canada to manage freshness of fruits, vegetables and flower displays. In Health Sciences segment, the Company offers a Wound Care solution for cleansing, debriding and moisturizing chronic and acute wounds, including diabetic ulcers and burns.

Company Address

PuriCore PLC

508 Lapp Rd
MALVERN   PA   19355-1214
P: +1484.3212700
F: +1484.3212725

Company Web Links